Development of a live attenuated antigenic marker classical swine fever vaccine

Abstract Until recently strategies for controlling Classical Swine Fever Virus (CSFV) involve either prophylactic vaccination or non-vaccination with elimination of infected herds depending on the epidemiological situation of the affected geographical area. Marker vaccines allowing distinction betwe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Virology (New York, N.Y.) N.Y.), 2009-02, Vol.384 (1), p.106-113
Hauptverfasser:	Holinka, L.G, Fernandez-Sainz, I, O'Donnell, V, Prarat, M.V, Gladue, D.P, Lu, Z, Risatti, G.R, Borca, M.V
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intranasal Amino Acid Sequence Animals Antigenic marker Antigens, Viral - analysis Attenuation Base Sequence Classical Swine Fever - immunology Classical Swine Fever Virus Classical swine fever virus - immunology disease prevention DIVA strategy epitopes Genetic marker Genetic Markers Genome, Viral Glycoproteins hog cholera humoral immunity immune response Immunization Infectious Disease Injections, Intramuscular Live attenuated vaccines live vaccines Marker vaccines Molecular Sequence Data Mutation Protection Serology Swine vaccination Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - chemistry Vaccines, Attenuated - genetics viral antigens Viral Vaccines Virulence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!